Acquired Neuromuscular Disorders: Pathogenesis,... May 2026

Treatment for acquired NMDs is largely clinically oriented and tailored to the specific etiology:

: Certain drugs, such as statins or cancer treatments, can induce Statin Myopathies or toxic neuropathies by interfering with cellular metabolism or inducing oxidative stress. Acquired Neuromuscular Disorders: Pathogenesis,...

: Identifying specific autoantibodies is crucial for confirming autoimmune NMDs like Myasthenia Gravis. Treatment for acquired NMDs is largely clinically oriented

: Electromyography (EMG) and nerve conduction studies are used to distinguish between primary muscle issues (myopathies) and nerve issues (neuropathies). such as statins or cancer treatments

The underlying mechanisms of acquired neuromuscular disorders typically involve an immune-mediated or metabolic disruption of the motor system:

: Disorders like Polymyositis involve direct inflammatory infiltration of muscle tissue, leading to fiber degeneration.

: Muscle biopsies and advanced imaging, such as MRI or peripheral nerve ultrasound, help visualize structural damage and inflammation. Treatment Strategies